SCHEMBL7328414

SCHEMBL7328414

CCn1ncc2c(Cl)c3cc(Br)ccc3nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
TRAP1 Q12931 1/20 0.40
HTT P42858 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PDE5A O76074 1/20 0.38
PDE10A Q9Y233 1/20 0.38
NT5E P21589 1/20 0.38
MPO P05164 1/20 0.37
CASP3 P42574 1/20 0.37
NR3C1 P04150 5/20 0.37
PGR P06401 1/20 0.36
PDE4B Q07343 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330632 0.82 PDE1A (0.44) CYP1A2CYP2D6CYP2C19PDE10APDE4B
SCHEMBL7328438 0.82 PIM1 (0.43) ADORA3ADORA2AADORA1PDE5APDE10A
SCHEMBL7332532 0.80 MAOA (0.50) CYP1A2CYP2C9CYP2C19ADORA3ADORA2A
SCHEMBL7332950 0.80 ADORA2A (0.38) ADORA3ADORA2AADORA1PDE5APDE10A
SCHEMBL7337974 0.80 ADORA3 (0.36) RXFP1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7330374 0.79 KMT2A (0.47) LMNA
SCHEMBL7332575 0.77 NPC1 (0.48) NR3C1KDM4ELMNAMAPTNPSR1
SCHEMBL7428137 0.77 NR3C1 (0.46) HTTADORA3ADORA2AADORA1PDE10A
SCHEMBL7330944 0.76 LMNA (0.44) HTTADORA3ADORA2AADORA1PDE5A
SCHEMBL7422521 0.76 LMNA (0.46) HTTADORA1PDE5APDE4BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5942520-A Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines CELL PATHWAYS, INC. (US) 1999-08-24 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed
US-5488055-A ADMINISTERING GMP HOSPHODIESTERASE INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND CARDIOVASCULAR DISORDERS SANOFI WINTHROP INC. (US) 1996-01-30 US disclosed